Hikma Pharmaceuticals PLC

Hikma Pharma Reaffirms FY25 Guidance Amid Strong Start

24 أبريل 2025 03:54:25 بحسب NASDAQ US Markets

Axsome Settles Patent Litigation With Hikma Related To Sunosi - Quick Facts

05 مارس 2025 07:55:56 بحسب NASDAQ US Markets

Hikma Pharma Inks Exclusive Commercial Deal With Emergent BioSolutions For KLOXXADO Nasal Spray 8 Mg

14 يناير 2025 08:49:06 بحسب NASDAQ US Markets

Hikma Pharma Extends Recall Of Acetaminophen Injection

23 يوليو 2024 03:11:57 بحسب NASDAQ US Markets

Hikma Pharma To Acquire Parts Of Xellia Pharma's US Finished Dosage Form Business And Assets

17 يونيو 2024 02:45:01 بحسب NASDAQ US Markets

Collegium Pharma Partners With Hikma For Authorized Generics Of Nucynta In US

29 أبريل 2024 09:07:49 بحسب NASDAQ US Markets

Hikma Pharma FY Profit Increases

22 فبراير 2024 03:52:27 بحسب NASDAQ US Markets

Hikma Pharma Launches Pain Relief Injection COMBOGESIC IV In US

05 فبراير 2024 07:48:52 بحسب NASDAQ US Markets

Guardant Health, Hikma To Offer Cancer Screening & Genomic Profiling Tests In Middle East & Africa

08 يناير 2024 03:35:52 بحسب NASDAQ US Markets

Hikma Pharmaceuticals (LSE:HIK) Price Target Increased by 9.63% to 2,311.15

01 سبتمبر 2023 01:51:58 بحسب NASDAQ Stocks

Hikma Pharma H1 Profit Down, Revenues Up; Lifts FY23 Forecast For Generics

03 أغسطس 2023 03:46:32 بحسب NASDAQ US Markets

Barclays Reiterates Hikma Pharmaceuticals (LSE:HIK) Equal Weight Recommendation

04 مايو 2023 20:30:46 بحسب NASDAQ Stocks

Hikma Pharma Appoints Riad Mishlawi As CEO, Effective Sept. 1

12 أبريل 2023 02:25:53 بحسب NASDAQ US Markets

Hikma Pharma FY22 Results Down, Lifts Dividend; Says Confident Of FY23 Growth; Stock Up

23 فبراير 2023 04:10:05 بحسب NASDAQ US Markets

Hikma accuses Amarin of suppressing generic versions of heart pill

22 فبراير 2023 17:13:30 بحسب NASDAQ US Markets

Hikma Pharma Launches Authorized Generic Version Of Xyrem In U.S.

03 يناير 2023 03:15:34 بحسب NASDAQ US Markets

Hikma Pharma Says Not Signed Licensing Agreement With Opiant Pharma

29 أبريل 2022 23:58:14 بحسب NASDAQ US Markets

U.S. FTC approves Hikma deal for Custopharm with conditions

19 أبريل 2022 14:04:52 بحسب NASDAQ US Markets

Hikma Pharma FY21 Profit Down, Lifts Dividend; Stock Down

24 فبراير 2022 03:43:25 بحسب NASDAQ US Markets

Hikma To Acquire Teligent's Canadian Assets - Quick Facts

17 يناير 2022 03:32:15 بحسب NASDAQ US Markets